FBInvestor
Stocks / Ani Pharmaceuticals Inc
Institutional Ownership

Ani Pharmaceuticals Inc

CUSIP 00182C103COMANIPQ1 2026

13D / 13G Filings
23
Schedule 13D/13G on record
Beneficial Filers
9
Distinct reporting persons
Largest Stake
12.9%
Max % of class reported
Institutional Holders
271
13F filers (latest quarter)

Beneficial Owners — Schedule 13D / 13G

23 filings · latest Nov 13, 2025

Export CSV — Pro
#FiledReporting PersonForm% of ClassSharesFiling
1Nov 13, 2025Integrated Core Strategies (Us) LLC13G/A11.0%65.2KSEC
2Oct 17, 2025Blackrock, Inc.13G/A11.3%2.52MSEC
3Aug 22, 2025Meridian Venture Partners II Gp, L.P. ("Gp")13D/A4.8%—SEC
4Jun 4, 2025Integrated Core Strategies (Us) LLC13G11.0%1.12MSEC
5Apr 10, 2025Millennium Management LLC13G/A11.0%818.3KSEC
6Mar 13, 2025Meridian Venture Partners II Gp, L.P. ("Gp")13D/A5.4%—SEC
7Jan 21, 2025Millennium Management LLC13G11.0%1.09MSEC
8Nov 13, 2024Rubric Capital Management LP13G/A0.3%56.7KSEC
9Mar 14, 2024Meridian Venture Partners II Gp, L.P.13D/A6.7%1.42MSEC
10Feb 13, 2024Vanguard Group Inc13G6.3%1.29MSEC

13 more beneficial-ownership filings on Premium

See the full Schedule 13D/13G history for Ani Pharmaceuticals Inc.

Unlock full history

Top Institutional Holders (13F)

Largest reported positions · latest quarter

View all →
#FundSharesValue
1Blackrock, Inc.2.75M$211.28M
2Soleus Capital Management, L.P.820.2K$63.08M
3State Street Corp771.6K$59.34M
4Tang Capital Management LLC707.5K$54.41M
5Goldentree Asset Management LP668.0K$51.30M
6Deep Track Capital, LP600.0K$46.14M
7Millennium Management LLC592.0K$45.53M
8Arrowstreet Capital, Limited Partnership564.4K$43.40M
9Dimensional Fund Advisors LP531.2K$40.84M
10Ubs Group AG497.7K$38.27M